BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Tesla
TSLA
|
+$468M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$266M |
| 5 |
Abbott
ABT
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$609M |
| 2 |
Apple
AAPL
|
+$577M |
| 3 |
Visa
V
|
+$476M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$434M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.37% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 6.83% |
| 4 | Healthcare | 6.12% |
| 5 | Communication Services | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
CRA International
CRAI
$1.07B
| $21.7K | ﹤0.01% |
254
-1,284
| -83% | -$104K |
|
3377
EverQuote
EVER
$864M
| $21.7K | ﹤0.01% |
665
-1,222
| -65% | -$40.7K |
|
|
ESPR
3378
DELISTED
Esperion Therapeutics
ESPR
| $21.6K | ﹤0.01% |
1,020
-1,997
| -66% | -$48.1K |
|
3379
RCI Hospitality Holdings
RICK
$230M
| $21.4K | ﹤0.01% |
324
-3,201
| -91% | -$225K |
|
|
VAPO
3380
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $21.3K | ﹤0.01% |
113
-214
| -65% | -$36.5K |
|
|
GORV
3381
DELISTED
Lazydays
GORV
| $21.1K | ﹤0.01% |
+32
| New | +$21.8K |
|
3382
Johnson Outdoors
JOUT
$512M
| $21.1K | ﹤0.01% |
174
-1,333
| -88% | -$179K |
|
3383
Veritone
VERI
$139M
| $21K | ﹤0.01% |
1,065
-2,387
| -69% | -$51.8K |
|
|
BCOV
3384
DELISTED
Brightcove, Inc.
BCOV
| $21K | ﹤0.01% |
1,461
-3,664
| -71% | -$58.8K |
|
|
SECO
3385
DELISTED
Secoo Holding Limited ADR
SECO
| $20.9K | ﹤0.01% |
850
+155
| +22% | +$3.85K |
|
3386
Aldeyra Therapeutics
ALDX
$86.9M
| $20.9K | ﹤0.01% |
1,843
-30,049
| -94% | -$361K |
|
|
CLVS
3387
DELISTED
Clovis Oncology, Inc.
CLVS
| $20.8K | ﹤0.01% |
3,586
-6,539
| -65% | -$38.3K |
|
|
CMRX
3388
DELISTED
Chimerix, Inc.
CMRX
| $20.7K | ﹤0.01% |
2,592
-40,782
| -94% | -$339K |
|
|
XOMA
3389
DELISTED
Xoma
XOMA
| $20.5K | ﹤0.01% |
602
-339
| -36% | -$11.4K |
|
3390
Immunic
IMUX
$226M
| $20.5K | ﹤0.01% |
167
+36
| +27% | +$4.98K |
|
|
ITIC
3391
Investors Title Co
ITIC
$534M
| $20.4K | ﹤0.01% |
117
-414
| -78% | -$72.1K |
|
3392
Napco Security Technologies
NSSC
$1.37B
| $20.4K | ﹤0.01% |
1,120
-2,636
| -70% | -$45.2K |
|
3393
Transcontinental Realty Investors
TCI
$312M
| $20.4K | ﹤0.01% |
603
-437
| -42% | -$11.3K |
|
3394
Biglari Holdings Class A
BH.A
$1.2B
| $20.3K | ﹤0.01% |
26
-14
| -35% | -$10.8K |
|
|
SIEN
3395
DELISTED
Sientra, Inc.
SIEN
| $20.1K | ﹤0.01% |
253
-527
| -68% | -$37.4K |
|
|
LORL
3396
DELISTED
Loral Space and Communications, Inc.
LORL
| $20K | ﹤0.01% |
516
-3,935
| -88% | -$149K |
|
3397
Aspen Aerogels
ASPN
$504M
| $20K | ﹤0.01% |
670
-7,650
| -92% | -$156K |
|
3398
NI Holdings
NODK
$313M
| $20K | ﹤0.01% |
1,052
-3,197
| -75% | -$61.6K |
|
3399
Security National Financial
SNFCA
$241M
| $19.9K | ﹤0.01% |
3,051
-4,676
| -61% | -$29.8K |
|
3400
Consolidated Water Co
CWCO
$502M
| $19.9K | ﹤0.01% |
1,694
-6,085
| -78% | -$75.3K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2021 Portfolio in Review
As of Q2 2021, BNP Paribas Financial Markets held 4,172 positions worth $75.6B, up 11% from $68.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets's Q2 2021 filing shows 175 new, 1,539 increased, 1,937 reduced and 124 closed positions. Its largest new stake was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M. The largest sale was Invesco QQQ Trust, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2021 buy was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $1.06B increase.
- BNP Paribas Financial Markets's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $609M.
- BNP Paribas Financial Markets fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $123M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $75.6B portfolio in Q2 2021.
- BNP Paribas Financial Markets opened 175 new positions and closed 124 in Q2 2021.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $75.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2021, filed 10 Aug 2021.